Long-term behavioral consequences of prenatal MDMA exposure

Physiology and Behavior

Volumn 96, Issue 4-5, 2009, Pages 593-601

  Thompson, Valerie B ^a   Heiman, Justin ^b   Chambers, James B ^b   Benoit, Stephen C ^b   Buesing, William R ^b   Norman, Mantana K ^b   Norman, Andrew B ^b   Lipton, Jack W ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Amphetamine challenge; Attention; Body composition; Hyperthermia; MDMA; Morris water maze; Open field; Prenatal; Progressive ratio responding; Radial arm maze; Self administration; Spatial learning

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; COCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; FEMALE; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; ATTENTION; BEHAVIOR, ANIMAL; COCAINE; CRITICAL PERIOD (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; FEMALE; GESTATIONAL AGE; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; SELF ADMINISTRATION; SEROTONIN AGENTS; SPATIAL BEHAVIOR; STATISTICS, NONPARAMETRIC;

EID: 60249100118     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.12.013     Document Type: Article

References (68)

1. Gurtman C.G., Morley K.C., Li K.M., Hunt G.E., and McGregor I.S. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol 446 1-3 (2002) 89-96
2. Ward J., Hall K., and Haslam C. Patterns of memory dysfunction in current and 2-year abstinent MDMA users. J Clin Exp Neuropsychol 28 3 (2006) 306-324
3. Wareing M., Murphy P.N., and Fisk J.E. Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology (Berl) 173 3-4 (2004) 391-397
4. Jacobsen L.K., Mencl W.E., Pugh K.R., Skudlarski P., and Krystal J.H. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173 3-4 (2004) 383-390
5. Morgan M.J., Impallomeni L.C., Pirona A., and Rogers R.D. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 31 7 (2006) 1562-1573
6. Gouzoulis-Mayfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert H.J., et al. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68 6 (2000) 719-725
7. Hatzidimitriou G., McCann U.D., and Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19 12 (1999) 5096-5107
8. Fischer C., Hatzidimitriou G., Wlos J., Katz J., and Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurosci 15 8 (1995) 5476-5485
9. Ho E., Karimi-Tabesh L., and Koren G. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). Neurotoxicol Teratol 23 6 (2001) 561-567
10. McElhatton P.R., Bateman D.N., Evans C., Pughe K.R., and Thomas S.H. Congenital anomalies after prenatal ecstasy exposure. Lancet 354 9188 (1999) 1441-1442
11. van Tonningen-van Driel M.M., Garbis-Berkvens J.M., and Reuvers-Lodewijks W.E. Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM). Ned Tijdschr Geneeskd 143 1 (1999) 27-31
12. Bayer S.A., Altman J., Russo R.J., and Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14 1 (1993) 83-144
13. Ricaurte G.A., Yuan J., and McCann U.D. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42 1 (2000) 5-10
14. Commins D.L., Vosmer G., Virus R.M., Woolverton W.L., Schuster C.R., and Seiden L.S. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241 1 (1987) 338-345
15. Liechti M.E., Saur M.R., Gamma A., Hell D., and Vollenweider F.X. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23 4 (2000) 396-404
16. Kelly P.A., Ritchie I.M., Quate L., McBean D.E., and Olverman H.J. Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain. Br J Pharmacol 137 7 (2002) 963-970
17. Koprich J.B., Chen E.Y., Kanaan N.M., Campbell N.G., Kordower J.H., and Lipton J.W. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol 25 5 (2003) 509-517
18. Ploeger G.E., Spruijt B.M., and Cools A.R. Spatial localization in the Morris water maze in rats: acquisition is affected by intra-accumbens injections of the dopaminergic antagonist haloperidol. Behav Neurosci 108 5 (1994) 927-934
19. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., and Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20 3 (2000) 1208-1215
20. Kalivas P.W., and Nakamura M. Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9 2 (1999) 223-227
21. Robbins T.W. Arousal systems and attentional processes. Biol Psychol 45 1-3 (1997) 57-71
22. Sawaguchi T., and Goldman-Rakic P.S. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71 2 (1994) 515-528
23. Williams M.T., Morford L.L., Wood S.L., Rock S.L., McCrea A.E., Fukumura M., et al. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res 968 1 (2003) 89-101
24. Crean R.D., Davis S.A., and Taffe M.A. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. Pharmacol Biochem Behav 87 1 (2007) 11-19
25. Hargreaves G.A., Hunt G.E., Cornish J.L., and McGregor I.S. High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner. Neuroscience 145 2 (2007) 764-774
26. Brown P.L., and Kiyatkin E.A. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions. Eur J Neurosci 20 1 (2004) 51-58
27. Clegg D.J., Brown L.M., Woods S.C., and Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55 4 (2006) 978-987
28. Taicher G.Z., Tinsley F.C., Reiderman A., and Heiman M.L. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377 6 (2003) 990-1002
29. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 95-122
30. Jicha G.A., and Salamone J.D. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 11 12 (1991) 3822-3829
31. Sotak B.N., Hnasko T.S., Robinson S., Kremer E.J., and Palmiter R.D. Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Res 1061 2 (2005) 88-96
32. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51 6 (2006) 801-810
33. Olausson P., Jentsch J.D., Tronson N., Neve R.L., Nestler E.J., and Taylor J.R. DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci 26 36 (2006) 9196-9204
34. Davis J., Tracy A., Chambers B., Shurdak J., Tschop M., Lipton J., Clegg D., and Benoit S. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 122 6 (2008) 1257-1263
35. Caine S.B., Lintz R., and Koob G.F. Intravenous drug self-administration techniques in animals. In: Sahgal A. (Ed). Behavioral neuroscience, a practical approach vol. 1 (1993), Oxford University Press, Oxford 117-143
36. Tsibulsky V.L., and Norman A.B. Real time computation of in vivo drug levels during drug self-administration experiments. Brain Res Brain Res Protoc 15 1 (2005) 38-45
37. McNay E.C., Williamson A., McCrimmon R.J., and Sherwin R.S. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 55 4 (2006) 1088-1095
38. Chadwick I.S., Curry P.D., Linsley A., Freemont A.J., and Doran B. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 84 6 (1991) 371
39. Dar K.J., and McBrien M.E. MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med 22 9 (1996) 995-996
40. Malberg J.E., Sabol K.E., and Seiden L.S. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278 1 (1996) 258-267
41. Dafters R.I. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berl) 114 3 (1994) 505-508
42. Battisti M.C., Noto A.R., Nappo S., and Carlini Ede A. A profile of Ecstasy (MDMA) use in Sao Paulo, Brazil: an ethnographic study. J Psychoactive Drugs 38 1 (2006) 13-18
43. McCaughan J.A., Carlson R.G., Falck R.S., and Siegal H.A. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States. Subst Use Misuse 40 9-10 (2005) 1503-1523
44. Huang J.S., Lee T.A., and Lu M.C. Prenatal programming of childhood overweight and obesity. Matern Child Health J 11 5 (2007) 461-473
45. Navarrete M., Nunez H., Ruiz S., Soto-Moyano R., Valladares L., White A., et al. Prenatal undernutrition decreases the sensitivity of the hypothalamo-pituitary-adrenal axis in rat, as revealed by subcutaneous and intra-paraventricular dexamethasone challenges. Neurosci Lett 419 2 (2007) 99-103
46. Feoli A.M., Leite M.C., Tramontina A.C., Tramontina F., Posser T., Rodrigues L., et al. Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition. Brain Res 1187 (2008) 33-41
47. Mokler D.J., Torres O.I., Galler J.R., and Morgane P.J. Stress-induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res 1148 (2007) 226-233
48. Koob G.F., Heinrichs S.C., Pich E.M., Menzaghi F., Baldwin H., Miczek K., Britton K.T.. The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found Symp 1993;172:277-89; 290-5.
49. van den Bos R., and Cools A.R. Switching to cue-directed behavior: specific for ventral striatal dopamine but not ventral pallidum/substantia innominata gaba as revealed by a swimming-test procedure in rats. Neuroscience 118 4 (2003) 1141-1149
50. Viggiano D., Grammatikopoulos G., and Sadile A.G. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav Brain Res 130 1-2 (2002) 181-189
51. Dazzi L., Spiga F., Pira L., Ladu S., Vacca G., Rivano A., et al. Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs. J Neurochem 76 4 (2001) 1212-1220
52. Chudasama Y., and Robbins T.W. Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology 29 9 (2004) 1628-1636
53. Tait D.S., and Brown V.J. Difficulty overcoming learned non-reward during reversal learning in rats with ibotenic acid lesions of orbital prefrontal cortex. Ann N Y Acad Sci 1121 (2007) 407-420
54. Baxter M.G., Browning P.G., and Mitchell A.S. Perseverative interference with object-in-place scene learning in rhesus monkeys with bilateral ablation of ventrolateral prefrontal cortex. Learn Mem 15 3 (2008) 126-132
55. Nagahama Y., Okina T., Suzuki N., Nabatame H., and Matsuda M. The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test. J Neurol Neurosurg Psychiatry 76 2 (2005) 169-175
56. Kim J.H., Kim D., Park S.H., Lee H.B., and Chung E.K. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse. J Nerv Ment Dis 195 7 (2007) 622-624
57. Evren C., Evren B., Yancar C., and Erkiran M. Temperament and character model of personality profile of alcohol- and drug-dependent inpatients. Compr Psychiatry 48 3 (2007) 283-288
58. Cain M.E., Saucier D.A., and Bardo M.T. Novelty seeking and drug use: contribution of an animal model. Exp Clin Psychopharmacol 13 4 (2005) 367-375
59. Lubman D.I., and Yucel M. Adolescent substance use and the developing brain. Dev Med Child Neurol 50 1 (2008) 76-77
60. Crews F., He J., and Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86 2 (2007) 189-199
61. van Nimwegen L., de Haan L., van Beveren N., van den Brink W., and Linszen D. Adolescence, schizophrenia and drug abuse: a window of vulnerability. Acta Psychiatr Scand Suppl 427 (2005) 35-42
62. Sadile A.G., Lamberti C., Siegfried B., and Welzl H. Circadian activity, nociceptive thresholds, nigrostriatal and mesolimbic dopaminergic activity in the Naples High- and Low-Excitability rat lines. Behav Brain Res 55 1 (1993) 17-27
63. Viggiano D., Vallone D., Welzl H., and Sadile A.G. The Naples High- and Low-Excitability rats: selective breeding, behavioral profile, morphometry, and molecular biology of the mesocortical dopamine system. Behav Genet 32 5 (2002) 315-333
64. Zeise M.L., Espinoza S., Gonzalez A., Cerda F.S., Nacarate J., Yanez C.G., et al. Methylphenidate improves cue navigation in the Morris water maze in rats. Neuroreport 18 10 (2007) 1059-1062
65. Schaefer T.L., Skelton M.R., Herring N.R., Gudelsky G.A., Vorhees C.V., and Williams M.T. Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J Neurochem 104 6 (2008) 1674-1685
66. Vorhees C.V., Schaefer T.L., and Williams M.T. Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution. Synapse 61 7 (2007) 488-499
67. Skelton M.R., Williams M.T., and Vorhees C.V. Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. Psychopharmacology (Berl) 189 3 (2006) 307-318
68. Cadilhac J., and Pons F. [Prenatal development of monoamine neurons in the rat]. C R Seances Soc Biol Fil 170 1 (1976) 25-30